197 related articles for article (PubMed ID: 20072653)
1. Peritoneal adhesion and angiogenesis in ovarian carcinoma are inversely regulated by hyaluronan: the role of gonadotropins.
Tzuman YC; Sapoznik S; Granot D; Nevo N; Neeman M
Neoplasia; 2010 Jan; 12(1):51-60. PubMed ID: 20072653
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin stimulation of MLS human epithelial ovarian carcinoma cells augments cell adhesion mediated by CD44 and by alpha(v)-integrin.
Schiffenbauer YS; Meir G; Maoz M; Even-Ram SC; Bar-Shavit R; Neeman M
Gynecol Oncol; 2002 Feb; 84(2):296-302. PubMed ID: 11812090
[TBL] [Abstract][Full Text] [Related]
3. Loss of ovarian function promotes angiogenesis in human ovarian carcinoma.
Schiffenbauer YS; Abramovitch R; Meir G; Nevo N; Holzinger M; Itin A; Keshet E; Neeman M
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13203-8. PubMed ID: 9371824
[TBL] [Abstract][Full Text] [Related]
4. Cell surface expression of hyaluronan on human ovarian cancer cells inversely correlates with their adhesion to peritoneal mesothelial cells.
Tamada Y; Takeuchi H; Suzuki N; Aoki D; Irimura T
Tumour Biol; 2012 Aug; 33(4):1215-22. PubMed ID: 22392500
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-regulated lymphangiogenesis in ovarian cancer is mediated by LEDGF-induced expression of VEGF-C.
Sapoznik S; Cohen B; Tzuman Y; Meir G; Ben-Dor S; Harmelin A; Neeman M
Cancer Res; 2009 Dec; 69(24):9306-14. PubMed ID: 19934313
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer spheroids use myosin-generated force to clear the mesothelium.
Iwanicki MP; Davidowitz RA; Ng MR; Besser A; Muranen T; Merritt M; Danuser G; Ince TA; Brugge JS
Cancer Discov; 2011 Jul; 1(2):144-57. PubMed ID: 22303516
[TBL] [Abstract][Full Text] [Related]
7. Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers.
Burleson KM; Casey RC; Skubitz KM; Pambuccian SE; Oegema TR; Skubitz AP
Gynecol Oncol; 2004 Apr; 93(1):170-81. PubMed ID: 15047232
[TBL] [Abstract][Full Text] [Related]
8. Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids.
Desjardins M; Xie J; Gurler H; Muralidhar GG; Sacks JD; Burdette JE; Barbolina MV
J Ovarian Res; 2014; 7():70. PubMed ID: 24999371
[TBL] [Abstract][Full Text] [Related]
9. Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content.
Nykopp TK; Rilla K; Sironen R; Tammi MI; Tammi RH; Hämäläinen K; Heikkinen AM; Komulainen M; Kosma VM; Anttila M
BMC Cancer; 2009 May; 9():143. PubMed ID: 19435493
[TBL] [Abstract][Full Text] [Related]
10. Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H.
Cannistra SA; Kansas GS; Niloff J; DeFranzo B; Kim Y; Ottensmeier C
Cancer Res; 1993 Aug; 53(16):3830-8. PubMed ID: 8339295
[TBL] [Abstract][Full Text] [Related]
11. Inducible hyaluronan production reveals differential effects on prostate tumor cell growth and tumor angiogenesis.
Bharadwaj AG; Rector K; Simpson MA
J Biol Chem; 2007 Jul; 282(28):20561-72. PubMed ID: 17502371
[TBL] [Abstract][Full Text] [Related]
12. Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma.
Lee SJ; Ghosh SC; Han HD; Stone RL; Bottsford-Miller J; Shen DY; Auzenne EJ; Lopez-Araujo A; Lu C; Nishimura M; Pecot CV; Zand B; Thanapprapasr D; Jennings NB; Kang Y; Huang J; Hu W; Klostergaard J; Sood AK
Clin Cancer Res; 2012 Aug; 18(15):4114-21. PubMed ID: 22693353
[TBL] [Abstract][Full Text] [Related]
13. Interactions of human peritoneal mesothelial cells with serous ovarian cancer cell spheroids--evidence for a mechanical and paracrine barrier function of the peritoneal mesothelium.
Stadlmann S; Feichtinger H; Mikuz G; Marth C; Zeimet AG; Herold M; Knabbe C; Offner FA
Int J Gynecol Cancer; 2014 Feb; 24(2):192-200. PubMed ID: 24407573
[TBL] [Abstract][Full Text] [Related]
14. Binding of ovarian cancer cells to immobilized hyaluronic acid.
Catterall JB; Gardner MJ; Jones LM; Turner GA
Glycoconj J; 1997 Nov; 14(7):867-9. PubMed ID: 9511993
[TBL] [Abstract][Full Text] [Related]
15. Binding of ovarian cancer cells to immobilized hyaluronic acid.
Catterall JB; Gardner MJ; Jones LM; Turner GA
Glycoconj J; 1997 Aug; 14(5):647-9. PubMed ID: 9298699
[TBL] [Abstract][Full Text] [Related]
16. The hyaluronan-related genes HAS2, HYAL1-4, PH20 and HYALP1 are associated with prognosis, cell viability and spheroid formation capacity in ovarian cancer.
Riecks J; Parnigoni A; Győrffy B; Kiesel L; Passi A; Vigetti D; Götte M
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3399-3419. PubMed ID: 35767191
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of CD44 expression by small interfering RNA to suppress the growth and metastasis of ovarian cancer cells in vitro and in vivo.
Li CZ; Liu B; Wen ZQ; Li HY
Folia Biol (Praha); 2008; 54(6):180-6. PubMed ID: 19393131
[TBL] [Abstract][Full Text] [Related]
18. VEGF expression and enhanced production by gonadotropins in ovarian epithelial tumors.
Wang J; Luo F; Lu JJ; Chen PK; Liu P; Zheng W
Int J Cancer; 2002 Jan; 97(2):163-7. PubMed ID: 11774259
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol inhibits ovarian cancer cell adhesion to peritoneal mesothelium in vitro by modulating the production of α5β1 integrins and hyaluronic acid.
Mikuła-Pietrasik J; Sosińska P; Książek K
Gynecol Oncol; 2014 Sep; 134(3):624-30. PubMed ID: 24995580
[TBL] [Abstract][Full Text] [Related]
20. Human ovarian tumour cells can bind hyaluronic acid via membrane CD44: a possible step in peritoneal metastasis.
Gardner MJ; Catterall JB; Jones LM; Turner GA
Clin Exp Metastasis; 1996 Sep; 14(4):325-34. PubMed ID: 8878406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
